Skip to main content
Premium Trial:

Request an Annual Quote

John Robson, John Carpenter, Joshua Wand, Richard DiMarchi, Ralph Di Libero

Premium

John Robson has become senior director for bioanalysis operations in Europe for MDS Pharma Services of Montreal. Prior to joining MDS, he was vice president of European operations and strategic product management for InnaPhase. Previously, he worked within the LC/MS business development group of Applied Biosystems/MDS Sciex in the UK and US. Robson holds an MS in organic geochemistry from the University of Newcastle upon Tyne in the UK and a doctorate in analytical chemistry from the University of Plymouth, also in the UK.

 

John Carpenter and Joshua Wand have joined the scientific advisory board of Houston-based RedStorm Scientific. Carpenter is an associate professor of pharmaceutical sciences at the University of Colorado, while Wand is a professor at the University of Pennsylvania.

 

Richard DiMarchi will retire as Eli Lilly’s group vice president for Lilly Research Laboratories by the end of April to become a tenured professor at Indiana University in Bloomington. He will remain a visiting Lilly scholar and consult for the company, which he joined in 1981.

 

Ralph Di Libero has joined Large Scale Biology of Vacaville, Calif., as senior director for business development and as vice president for sales for the company’s biomanufacturing division in Owensboro, Ky. He joins the company from PolyPeptide Laboratories, where he was a sales manager. Previously, he held sales posts at Bachem/ Peninsula Laboratories and Bio-Rad Laboratories. Di Libero holds an undergraduate degree from the University of California, Santa Barbara, and a graduate degree from the University of New Mexico in Albuquerque.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.